Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-02-21
1998-06-30
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514102, 514108, A61K 31135, A61K 3166
Patent
active
057734771
ABSTRACT:
The present invention provides novel methods of treating or preventing osteoporosis comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different provided that, when R.sup.1 and R.sup.2 are the same, each is a methyl or ethyl group, and, when R.sup.1 and R.sup.2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof; together with a bone resorption inhibiting polyphosphonate.
REFERENCES:
patent: 3683080 (1972-08-01), Francis
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Niikura et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5441986 (1995-08-01), Thompson
patent: 5455275 (1995-10-01), Fontana
patent: 5550164 (1996-08-01), Fontana
U.S. Pharmacopeia, 12601 Twinbrook Parkway, Rockville, Maryland, 30 (1998).
MacLean David B.
Thompson David D.
Butterfield Garth
Ginsburg Paul H.
Goldberg Jerome D.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Combination therapy to treat osteoporosis - polyphosphonates and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy to treat osteoporosis - polyphosphonates and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy to treat osteoporosis - polyphosphonates and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1859860